Abstract
Introduction: Several studies on COVID-19 and pregnancy have been published recently, but few studies have evaluated the impact of this pandemic on maternal mental health particularly in low-resource setting. Aim: To determine the prevalence and predictors of COVID-19-related depression, anxiety and stress symptoms among pregnant women. Materials and methods: This was a questionnaire-based cross-sectional study conducted among 456 pregnant women attending prenatal care at Abakaliki, Nigeria during COVID-19-related lockdown. They were screened for psychological morbidities using DASS 21 (Depression, Anxiety and Stress Scale). Results: Severe and extremely severe depression were reported in 33 (7.2%) and 29 (6.4%) participants respectively. 15 (3.3%) and 35 (7.7%) women had severe and extremely severe anxiety respectively. 105 (23%) had severe anxiety whereas 76 (16.7%) reported extremely severe stress. Multiparity (2 - 4) and occupations such as trading and farming were predictors of depression whereas grandmultiparity, urban residence and trading were identified as predictors of anxiety and stress. Conclusion: Depression, anxiety and stress symptoms were relatively common among pregnant women during COVID-19-related lockdown in Abakaliki, Nigeria. There is a need to integrate screening for depression, anxiety and stress in existing antenatal care programs so as to identify and prevent long term adverse psychological outcome related to COVID-19 pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research and Ethics Committee of Alex Ekwueme Federal University Teaching Hospital,Abakaliki,Nigeria
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available upon request
